Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MOMELOTINIB for Essential thrombocythaemia: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where MOMELOTINIB was used for Essential thrombocythaemia.

Most Reported Side Effects for MOMELOTINIB

Side Effect Reports % Deaths Hosp.
Thrombocytopenia 89 9.8% 2 12
Death 77 8.5% 74 13
Drug ineffective 75 8.3% 5 1
Anaemia 59 6.5% 5 10
Diarrhoea 51 5.6% 4 17
Myelofibrosis 51 5.6% 11 10
Condition aggravated 49 5.4% 3 7
Dizziness 41 4.5% 2 2
Pneumonia 41 4.5% 13 27
Fatigue 39 4.3% 3 7
Platelet count decreased 38 4.2% 6 10
Haemoglobin decreased 37 4.1% 5 12
Neuropathy peripheral 34 3.7% 0 1
Nausea 31 3.4% 1 6
Splenomegaly 30 3.3% 3 4

Other Indications for MOMELOTINIB

Myelofibrosis (526) Product used for unknown indication (224) Primary myelofibrosis (64) Anaemia (52) Myeloproliferative neoplasm (19) Polycythaemia vera (9) Myelodysplastic syndrome (7)

Other Drugs Used for Essential thrombocythaemia

RUXOLITINIB (1,788) ANAGRELIDE (797) HYDROXYUREA (629) PEGINTERFERON ALFA-2A (259) ROPEGINTERFERON ALFA-2B-NJFT (123) ASPIRIN (77) PACRITINIB (66) LENALIDOMIDE (41) FEDRATINIB (28) XAGRID (27)

Related Pages

MOMELOTINIB Full Profile All Essential thrombocythaemia Drugs MOMELOTINIB Demographics MOMELOTINIB Timeline